Assignee
SYGNIS BIOSCIENCE GMBH & CO KG
DE·9 granted patents·3 pending applications·76 citations·filing 2001–2009
Top patents by PatentIndex Score
12 records- 0192US7884069B2Methods of treating neurological conditions with hematopoeitic growth factorsSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2007·Granted Feb 8, 2011·32 cites·23 claims
- 0288US7785601B2Methods of treating neurological conditions with hematopoietic growth factorsSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2003·Granted Aug 31, 2010·30 cites·19 claims
- 0375US8349619B2Method for detecting and analyzing protein interactions in-vivoSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2009·Granted Jan 8, 2013·7 cites·6 claims
- 0466US7695723B2Methods of treating neurological conditions with hematopoietic growth factorsSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2004·Granted Apr 13, 2010·4 cites·6 claims
- 0562US8053407B2Methods of treating neurological conditions with hematopoeitic growth factorsSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2007·Granted Nov 8, 2011·0 cites·10 claims
- 0657US7575857B2Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disordersSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2003·Granted Aug 18, 2009·1 cites·10 claims
- 0754US2009305974A1Therapeutic indications of colony stimulating factorsSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2007·Application pending·0 cites
- 0854US2009305289A1Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseasesSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2009·Application pending·0 cites
- 0950US7361502B2Nucleic acid molecule encoding a neuronal serine-threonine protein kinaseSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2001·Granted Apr 22, 2008·1 cites·5 claims
- 1049US7585635B2Method for detecting and analyzing protein interactions in vivoSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2003·Granted Sep 8, 2009·1 cites·4 claims
- 1143US2010284926A1Use of g-csf for the treatment of strokeSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2008·Application pending·0 cites
- 1238US7361681B2Method of treating amytrophic lateral sclerosis using melatoninSYGNIS BIOSCIENCE GMBH & CO KG·Filed 2003·Granted Apr 22, 2008·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when SYGNIS BIOSCIENCE GMBH & CO KG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →